Sepsis

2023 - 1 - 9

Post cover
Image courtesy of "Medical Device Network"

Asep and Seaspring to commercialise sepsis diagnosis technology ... (Medical Device Network)

Asep Medical Holdings has signed a letter of intent (LOI) with Seaspring to establish a joint venture (JV) for regulatory approval and commercialisation of ...

Under the deal, Seaspring will provide the capital for the JV to carry out its business operations. Seaspring founder and managing director Shaikh Isa bin Khalid Al-Khalifa said: “With the introduction of Asep ‘s novel sepsis diagnostic technologies in Bahrain, we look forward to supporting and advancing the healthcare system in the country and that of the wider region. Asep Medical Holdings has signed a letter of intent (LOI) with Seaspring to establish a joint venture (JV) for regulatory approval and commercialisation of

Post cover
Image courtesy of "PRNewswire"

PERSOWN Inc. to launch SMASH-H, a near-real-time Sepsis ... (PRNewswire)

PRNewswire/ -- Medical information technology and diagnostics company PERSOWN, Inc. is addressing the global burden of sepsis with the launch of the open...

[Sepsis Innovation Collaborative](https://c212.net/c/link/?t=0&l=en&o=3750810-1&h=640954481&u=https%3A%2F%2Fwww.sepsisinnovation.org%2F&a=Sepsis+Innovation+Collaborative), with the goal of sharing unified data for analyzing best practices. - The Use of Patient Monitoring Systems to Improve Sepsis Recognition and Outcomes: A Systematic Review. [SAS® artificial intelligence](https://c212.net/c/link/?t=0&l=en&o=3750810-1&h=56448424&u=https%3A%2F%2Fwww.sas.com%2Fen_us%2Fsolutions%2Fai.html&a=SAS%C2%AE%C2%A0artificial+intelligence) tools to provide time-series predictive analytics. "With SAS' trustworthy AI, machine learning and cloud-based capabilities, our partners like PERSOWN are developing solutions that have a measurable impact on improving health outcomes," said [Steve Kearney](https://c212.net/c/link/?t=0&l=en&o=3750810-1&h=3308067579&u=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fstephen-kearney-83a5a670%2F&a=Steve+Kearney), Global Medical Director at SAS. Gale and Kendall K. "By focusing on high-performance, clinically validated predictive models, sepsis time-zero can be identified earlier and lead to significant reduction in inpatient sepsis mortality rates to the 10-12% range." "There is a particular opportunity on the ambulatory side to reduce sepsis readmission rates by reducing transaction friction times," said [here](https://c212.net/c/link/?t=0&l=en&o=3750810-1&h=1073751643&u=https%3A%2F%2Fpersown.com%2Fsmash-h%2F&a=here) to learn more and [register.](https://c212.net/c/link/?t=0&l=en&o=3750810-1&h=4101989042&u=https%3A%2F%2Fpersown.com%2Fcontact-us%2F&a=register.) SMASH-H will provide hospitals access to a common set of predictive models designed to enhance existing IT platforms, monitoring tools and diagnostic products. Sepsis is a common reason for hospital admission and readmission, with estimated incidence of 6%. [PERSOWN, Inc.](https://c212.net/c/link/?t=0&l=en&o=3750810-1&h=4033756150&u=https%3A%2F%2Fpersown.com%2F&a=PERSOWN%2C+Inc.) is addressing the global burden of sepsis with the launch of the open platform SMASH-H (Sepsis Monitoring and Alerting System for Hospitals and Homes), powered by healthcare analytics from [SAS](https://c212.net/c/link/?t=0&l=en&o=3750810-1&h=3776254149&u=https%3A%2F%2Fwww.sas.com%2Fen_us%2Fhome.html&a=SAS). [Eric Doherty](https://c212.net/c/link/?t=0&l=en&o=3750810-1&h=3932197439&u=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fericdohertypresidentpersown%2F&a=Eric+Doherty), President at PERSOWN.

Post cover
Image courtesy of "Mirage News"

Anticancer drugs: new hope for sepsis treatment (Mirage News)

The body's extreme response to infection, a condition called sepsis, kills 11 million people every year. This is because to survive a serious.

By forming a complex with the cell’s DNA, these drugs avoid the binding of factors that drive the expression of these genes. The Innate Immunity and Inflammation research group at the IGC focuses on this second aspect, which is still not a part of the therapeutic intervention on sepsis. This is because to survive a serious infection it is not enough to get rid of the infectious agent, which is currently done with relative effectiveness; it is also necessary to limit the damage these and the immune response cause on the organs.

Explore the last week